IV iron for peri-operative hip fractures reduces transfusions

In this trial of 200 hip fracture patients, they were randomized to IV iron or standard treatment. The iron group had lower rates of blood transfusions (41% vs 33%), which was significantly lower in the subgroup of patients with intra-capsular fractures (46% vs 14%). There were no significant differences in LOS or mortality. IV iron peri-operatively may reduce transfusion need in patients with hip fractures (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment